Key Takeaways The U.S. Supreme Court on Thursday, May 14, 2026, allowed Mifepristone to remain available through telehealth consultations and mail delivery nationwide while litigation over the drug’s regulation continues in the lower courts. This determination, after an earlier administrative stay extension, temporarily preserves one of the most widely used forms of abortion access in […]
